Status:

UNKNOWN

Ozurdex in Suboptimal Diabetic Macular Edema Patients

Lead Sponsor:

Uptown Eye Specialists

Conditions:

Diabetic Macular Edema

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The primary focus of this study is to understand the anatomic and visual outcomes of patients with refractory and suboptimal treatment response diabetic macular edema (DME) using anti-vascular endothe...

Detailed Description

Diabetic macular edema (DME) is the most common cause of vision loss in young patients with diabetes. Its pathophysiology starts with decreased retinal oxygen tension that manifests as retinal capilla...

Eligibility Criteria

Inclusion

  • Treatment-native patients with DME secondary to type I or type II diabetes mellitus
  • Patients who require intravitreal anti-VEGF treatment
  • Able to understand English and complete a pain assessment
  • Suboptimal DME responders in patients who have received 3 or 6 eylea injections (non-cytokine group)

Exclusion

  • Deafness or communication disorder, known Dementia, Severe COPD/Asthma (severe lung disorder), Severe OSA, Psychiatric or Anxiety conditions, involuntary movement disorders, allergy to the anesthesia, any conditions requiring intraoperative iris manipulation, any prior ocular surgery; all patients who may need translation, are illiterate, or unable to provide consent.
  • Pre-existing ocular pathology confounding outcome (i.e. uveitis, retinal vascular disease, macular degeneration etc.)
  • Pre-existing uncontrolled glaucoma/high IOP
  • Patients under 18

Key Trial Info

Start Date :

May 25 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 29 2021

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT04856397

Start Date

May 25 2021

End Date

December 29 2021

Last Update

May 12 2021

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Ozurdex in Suboptimal Diabetic Macular Edema Patients | DecenTrialz